MedPath

Comparing Levobupivacaine 0.25% and Ropivacaine 0.25% for caudal epidural anaesthesia for infra umbilical surgeries in childre

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/064524
Lead Sponsor
Dr Manchikanti V D Avinash
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ASA 1 AND 2

2.Patients undergoing elective infraumbilical surgeries

3.Parental consent

4.Duration of surgery less than 1 hour

Exclusion Criteria

1.Patients who are allergic to local anaesthetics

2. Patients with coagulation abnormalities

3.Patients with spinal abnormalities and neurological deficits.

4. Patients with infection at the site of block

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effectiveness of analgesia and drug with less toxic effect of 0.25% Levobupivacaine and 0.25% Ropivacaine in Paediatric patients undergoing infra umbilical surgeries under caudal epidural anaesthesia.Timepoint: 5,10,15,20,25,30,35,40,45,50,55 and 60 minutes
Secondary Outcome Measures
NameTimeMethod
Duration of post operative analgesia and complications if anyTimepoint: 5,10,15,20,25,30,35,40,45,50,55 and 60 minutes
© Copyright 2025. All Rights Reserved by MedPath